Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb:142:333-370.
doi: 10.1016/j.jclinepi.2021.11.010. Epub 2021 Nov 14.

International alliance and AGREE-ment of 71 clinical practice guidelines on the management of critical care patients with COVID-19: a living systematic review

Affiliations

International alliance and AGREE-ment of 71 clinical practice guidelines on the management of critical care patients with COVID-19: a living systematic review

Yasser S Amer et al. J Clin Epidemiol. 2022 Feb.

Abstract

Objective: We aimed to systematically identify and critically assess the clinical practice guidelines (CPGs) for the management of critically ill patients with COVID-19 with the AGREE II instrument.

Study design and setting: We searched Medline, CINAHL, EMBASE, CNKI, CBM, WanFang, and grey literature from November 2019 - November 2020. We did not apply language restrictions. One reviewer independently screened the retrieved titles and abstracts, and a second reviewer confirmed the decisions. Full texts were assessed independently and in duplicate. Disagreements were resolved by consensus. We included any guideline that provided recommendations on the management of critically ill patients with COVID-19. Data extraction was performed independently and in duplicate by two reviewers. We descriptively summarized CPGs characteristics. We assessed the quality with the AGREE II instrument and we summarized relevant therapeutic interventions.

Results: We retrieved 3,907 records and 71 CPGs were included. Means (Standard Deviations) of the scores for the 6 domains of the AGREE II instrument were 65%(SD19.56%), 39%(SD19.64%), 27%(SD19.48%), 70%(SD15.74%), 26%(SD18.49%), 42%(SD34.91) for the scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, editorial independence domains, respectively. Most of the CPGs showed a low overall quality (less than 40%).

Conclusion: Future CPGs for COVID-19 need to rely, for their development, on standard evidence-based methods and tools.

Keywords: AGREE II tool; COVID-19; guidelines; intensive care; quality; rapid guidelines.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PRISMA Flow Diagram of study selection.

Similar articles

Cited by

References

    1. Dagens A, Sigfrid L, Cai E, Lipworth S, Cheung V, Harris E, et al. Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review. BMJ. 2020:369. - PMC - PubMed
    1. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. Who.int. 2020 [cited 6 April 2020]. Available at: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re...
    1. Covid19.who.int. 2020. WHO Coronavirus Disease (COVID-19) Dashboard. [online] Available at: <https://covid19.who.int/> [Accessed 15 Feb 2021].
    1. Bong CL, Brasher C, Chikumba E, McDougall R, Mellin-Olsen J, Enright A. The COVID-19 Pandemic: effects on low- and middle-income countries. Anesth Analg. 2020;131(1):86–92. doi: 10.1213/ANE.0000000000004846. - DOI - PMC - PubMed
    1. Iyengar K, Mabrouk A, Jain VK, Venkatesan A, Vaishya R. Learning opportunities from COVID-19 and future effects on health care system. Diabetes Metab Syndr. 2020;14(5):943–946. doi: 10.1016/j.dsx.2020.06.036. Epub 2020 Jun 20. PMID: 32599533; PMCID: PMC7305503. - DOI - PMC - PubMed

Publication types